SCHEMBL30810295

SCHEMBL30810295

COC(=O)c1cc(Cl)cc(C2CCOC2)c1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ TSHR P16473 1/20 0.38
▸ SERPINH1 P50454 1/20 0.37
▸ GCK P35557 1/20 0.37
▸ HCRTR1 O43613 1/20 0.37
▸ HCRTR2 O43614 1/20 0.37
▸ HPGD P15428 2/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ SLC6A3 Q01959 1/20 0.35
▸ ACLY P53396 1/20 0.35
▸ APLNR P35414 2/20 0.35
▸ ABL1 P00519 1/20 0.34
▸ SERPINE1 P05121 1/20 0.34
▸ DRD2 P14416 1/20 0.34
▸ PDE4A P27815 1/20 0.34
▸ PDE4B Q07343 1/20 0.34
▸ PDE4C Q08493 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30810272 0.89 KDM4E (0.41) KDM4EGCKHSD17B10ACLYAPLNR
SCHEMBL19612159 0.85 KDM4E (0.43) KDM4EALDH1A1SMN1; SMN2TSHRSERPINH1
SCHEMBL30810455 0.80 TDP1 (0.39) KDM4EALDH1A1SMN1; SMN2TSHRGCK
SCHEMBL30810337 0.78 CFTR (0.51) KDM4EALDH1A1SMN1; SMN2TSHRHPGD
SCHEMBL13279910 0.75 HCRTR1 (0.39) KDM4EALDH1A1SMN1; SMN2TSHRHCRTR1
SCHEMBL13280393 0.73 EZH2 (0.41) KDM4EALDH1A1HCRTR1HCRTR2HPGD
SCHEMBL19612152 0.73 KDM4E (0.48) KDM4EALDH1A1SMN1; SMN2TSHRHSD17B10
SCHEMBL29964430 0.72 OPRK1 (0.42) ALDH1A1SMN1; SMN2TSHRGCKHSD17B10
SCHEMBL29964499 0.72 GAA (0.46) KDM4EALDH1A1SMN1; SMN2TSHRGCK
SCHEMBL13280007 0.71 EZH2 (0.54) HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4583870-A2 MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER Mito Biopharma, LLC (US) 2025-07-16 — — EP disclosed
WO-2024054766-A2 MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER MITO BIOPHARMA, LLC (US) 2024-03-14 — — WO disclosed
Send feedback